https://www.vonjohcp.com/request-a-vonjo-representative https://www.vonjohcp.com/about-myelofibrosis https://www.vonjohcp.com/sites/default/files/2026-10/Occurrence-of-thrombocytopenia-and-anemia-in-myelofibrosis.svg https://www.vonjohcp.com/themes/custom/vonjohcp/images/sobi-logo.png https://www.vonjohcp.com/themes/custom/vonjohcp/images/vonjo-pacritinib-capsules.png https://www.vonjohcp.com/moa https://www.vonjohcp.com/sites/default/files/styles/large/public/2026-10/vonjo-mechanism-of-action-video.jpg?itok=Q9E67ieB PP-25369_VONJO_US_VONJO_ HCP MOA Video_ProRes VONJO mechanism of action—a different MOA for a different type of myelofibrosis (MF) https://player.vimeo.com/video/1221259097?h=b0c6d767bf&badge=0&autopause=0&player_id=0&app_id=58479 https://www.vonjohcp.com/sites/default/files/2026-10/jak2-inhibitor-table.svg https://www.vonjohcp.com/efficacy https://www.vonjohcp.com/sites/default/files/2026-10/spleen-reduction-in-myelofibrosis-chart.svg https://www.vonjohcp.com/sites/default/files/2026-10/spleen-reduction-in-myelofibrosis-data.svg https://www.vonjohcp.com/sites/default/files/styles/large/public/2026-10/change-from-baseline-vonjo-vs-bat-chart.png?itok=4D6aAjXB https://www.vonjohcp.com/sites/default/files/2026-10/myelofibrosis-symptom-reduction-chart.svg https://www.vonjohcp.com/sites/default/files/2026-10/myelofibrosis-symptom-reduction-data.svg https://www.vonjohcp.com/sites/default/files/2026-10/myelofibrosis-transfusion-independence-chart.svg https://www.vonjohcp.com/sites/default/files/2026-10/myelofibrosis-transfusion-reduction-chart.svg https://www.vonjohcp.com/sites/default/files/2026-10/PGIA-chart.svg https://www.vonjohcp.com/sites/default/files/inline-images/persist-2-trial-design-thumbnail.png https://www.vonjohcp.com/sites/default/files/inline-images/persist-2-trial-design-thumbnail.png PERSIST-2 Myelofibrosis Trial Design Watch a detailed explanation of the PERSIST-2 Study. https://player.vimeo.com/video/1221270675?h=58277b4994&badge=0&autopause=0&player_id=0&app_id=58479 https://www.vonjohcp.com/ https://www.vonjohcp.com/sites/default/files/styles/large/public/2026-10/bart-scott-md-discusses-myelofibrosis-progression.jpg?itok=6meDU_ey Listen to Bart Scott, MD talk about the impact of thrombocytopenia Dr. Scott specializes in myeloid malignancies and myeloproliferative neoplasms. For him, thrombocytopenia is not only a sign that a patient’s MF is progressing, it also presents a difficult challenge in managing their disease. https://player.vimeo.com/video/957376229 https://www.vonjohcp.com/themes/custom/vonjohcp/images/vonjo-pacritinib-capsules.png https://www.vonjohcp.com/sites/default/files/styles/background_compressed/public/2026-10/myelofibrosis-progression-hero.jpg?itok=JtBwBlj8 https://www.vonjohcp.com/sites/default/files/styles/large/public/2026-10/bart-scott-md-discusses-myelofibrosis-progression.jpg?itok=6meDU_ey https://www.vonjohcp.com/themes/custom/vonjohcp/images/sobi-logo.png https://www.vonjohcp.com/safety-and-dosing-administration https://www.vonjohcp.com/sites/default/files/2026-05/chart-adverse-reactions-reported.svg https://www.vonjohcp.com/persist-2-trial-study-design https://www.vonjohcp.com/sites/default/files/2026-10/vonjo-study-design.svg https://www.vonjohcp.com/sites/default/files/2026-10/most-common-bat-agents.svg https://www.vonjohcp.com/themes/custom/vonjohcp/images/sobi-logo.png https://www.vonjohcp.com/themes/custom/vonjohcp/images/vonjo-pacritinib-capsules.png https://www.vonjohcp.com/myelofibrosis-nccn-guidelines https://www.vonjohcp.com/support https://www.vonjohcp.com/sites/default/files/styles/large/public/2024-09/VONJO_connect_RGB_POS.png?itok=Fs-DOPHF